http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
양측 부신절제술후 연속적으로 병발된 폐효모균증 및 폐결핵
이원영 ( Won Young Lee ),조영석 ( Young Suk Cho ),김미영 ( Mi Young Kim ),안리숙 ( Rhee Sook Ahn ),송소향 ( So Hyang Song ),이숙영 ( Sook Young Lee ),김영균 ( Young Kyoon Kim ),김관형 ( Kwan Hyung Kim ),박성학 ( Sung Hak Park ) 대한결핵 및 호흡기학회 1995 Tuberculosis and Respiratory Diseases Vol.42 No.1
정상 및 본태성고혈압 환자에서 미세단백뇨 ( Microalbuminuria ) 에 대한 Enalapril 단독요법의 효과
김진일(Jin Il Kim),박인수(In Soo Park),안리숙(Lee Sook Ahn),박지원(Ji Won Park),윤호중(Ho Joong Youn),정욱성(Wook Sung Chung),김재형(Jae Hyung Kim),문언수(Un Soo Moon),최규보(Kyu Bo Choi),홍순조(Soon Jo Hong) 대한내과학회 1995 대한내과학회지 Vol.49 No.1
Objectives: Prognosis of essential hypertension has been proven to be majorly depend on the target organ damages(TODs). Renal target organ damage serves about 10% mortality in those essential hypertension. Thus prediction of renal TOD is very important in management of essential hypertension. Urinary microalbumin or microalbumin excretion rate (UAER) is thought to be useful early predictive for the renal TOD in diabetes and hypertension. Approximately 40 percent of essential hypertensive patients has been known to have increased UAER. And angiotensin-converting enzyme inhibitor (ACEi) has thought to be effective in decreasing microalbuminuria. This study was designed to evaluate effectiveness of ACEi(enalapril) on significant microalbuminuria in essential hypertension. Methods: 40 cases (M:F=13:27) were subjected in this study. After 4 weeks wash-out period, 24-hour ambulatory blood pressure monitoring (24-hr ABPM) and subsequent measurement of microalbuminuria in 24-hr urine were performed. After 12 weeks enalapril monotherapy, above examinations were repeated and the results were compared. Depend on initial results of 24-hr ABPM and UAER, the subjects were divided into 2 groups each; normotensive, hypertensive, UAER (above 20 ug/min) and non-UAER(less than 20 ug/min) group. Results. 1) After enalapril monotherapy for 12 weeks, whole-day average blood pressure was decreased significantly in whole subjects(n=40, from 145.68/ 94.92 to 123.55/ 81.50, p=0.0001) as well as in hypertensive group(n = 30, from 155.17/100.13 mm Hg to 126.30/83.70 mmHg, p=0.0001), UAER group(n=16, from 153.94/99.31 mmHg to 125.44/ 81.44 mmHg, p=0.0001) and non UAER group(n =24, from 140.17/92.00 mmHg to 122.29/ 81.54 mmHg, p=0.0006) except in normatensive group (n=10, from 117,20/79.30mmHg to 115.30/74.90 mmHg, p=NS). 2) UAER was significantly diminished in whole subjects( 28.14 30.54 vs 10.65 13.56 g/min, p= 0.0014), also in UAER group (from 54.91 33.36 g /min to 17.02 18.86 g/min, p=0.0004), in non UAEB group( from 10.29 4.95 to 6.40 5.70 g/ min,p = 0.015,n = 24), and in hypertensive group (from 32.09 33.25 g/min to 10.95 14.25 g/min, p = 0.0022), but not in normotensive group(from 16.31 16.46 g/min to 9.75 12.24 g/min, p=0.326). 3) Lipid profiles including total cholesterol, triglyceride and HDL-cholesterol were not changed in all groups. Conclusion; Microalbuminuria can be decreased by the administration of ACEi in essential hypertensives. And further study would be necessary to clarify those mechanisms.